Skip to Content

1,721 Results Found

  • Review
  • Open Access
36 Citations
6,997 Views
23 Pages

Application of Machine Learning for Differentiating Bone Malignancy on Imaging: A Systematic Review

  • Wilson Ong,
  • Lei Zhu,
  • Yi Liang Tan,
  • Ee Chin Teo and ,
  • Jiong Hao Tan,
  • Naresh Kumar,
  • Balamurugan A. Vellayappan,
  • Beng Chin Ooi,
  • Swee Tian Quek and
  • James Thomas Patrick Decourcy Hallinan
  • + 6 authors+ 1 author

18 March 2023

An accurate diagnosis of bone tumours on imaging is crucial for appropriate and successful treatment. The advent of Artificial intelligence (AI) and machine learning methods to characterize and assess bone tumours on various imaging modalities may as...

(This article belongs to the Special Issue Artificial Intelligence and MRI Characterization of Tumors)
  • Article
  • Open Access
7 Citations
4,205 Views
16 Pages

Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy

  • Antonio Laghezza,
  • Luca Piemontese,
  • Leonardo Brunetti,
  • Alessia Caradonna and ,
  • Mariangela Agamennone,
  • Antonella Di Pizio,
  • Giorgio Pochetti,
  • Roberta Montanari,
  • Davide Capelli and
  • Paolo Tortorella
  • + 7 authors+ 2 authors

Matrix metalloproteinases (MMPs) are a family of enzymes involved at different stages of cancer progression and metastasis. We previously identified a novel class of bisphosphonic inhibitors, selective for MMPs crucial for bone remodeling, such as MM...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
3 Citations
2,562 Views
19 Pages

Steroids and Malignancy Increase Local Heparanase and Decrease Markers of Osteoblast Activity in Bone Tissue Microcirculation

  • Keren Asayag,
  • Eli Peled,
  • Mai Assalia,
  • Yonatan Crispel and ,
  • Chen Yanovich,
  • Haim Cohen,
  • Anat Keren-Politansky and
  • Yona Nadir
  • + 3 authors+ 0 author

26 November 2024

Bone metastasis and steroids are known to activate the coagulation system and induce osteoporosis, pathological bone fractures, and bone pain. Heparanase is a protein known to enhance the hemostatic system and to promote angiogenesis, metastasis, and...

(This article belongs to the Section Biological Factors)
  • Case Report
  • Open Access
20 Citations
7,652 Views
17 Pages

Malignant Transformation of Giant Cell Tumour of Bone: A Review of Literature and the Experience of a Referral Centre

  • Sabrina Vari,
  • Federica Riva,
  • Concetta Elisa Onesti,
  • Antonella Cosimati and ,
  • Davide Renna,
  • Roberto Biagini,
  • Jacopo Baldi,
  • Carmine Zoccali,
  • Vincenzo Anelli and
  • Virginia Ferraresi
  • + 9 authors+ 4 authors

14 September 2022

Giant cell tumour of bone (GCTB) is a benign, locally aggressive primary bone neoplasm that represents 5% of all bone tumours. The principal treatment approach is surgery. Although generally GCTB is considered only a locally aggressive disease, it ca...

(This article belongs to the Special Issue Bone and Soft Tissue Sarcomas - Basic Research and Multimodal Treatment Concepts)
  • Article
  • Open Access
638 Views
15 Pages

9 June 2026

Background/Objectives: Secondary malignant neoplasms of the bone are a major concern for cancer patients, with significant morbidity and mortality despite advancements in cancer care. The current literature reports demographic variability, but popula...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Review
  • Open Access
3 Citations
3,564 Views
21 Pages

Malignant Transformation of Musculoskeletal Lesions with Imaging–Pathology Correlation—Part 1: Bone Lesions

  • Hyang Sook Jeong,
  • Seul Ki Lee,
  • Jee-Young Kim,
  • Changyoung Yoo and
  • Min Wook Joo

8 December 2025

Background/Objectives: Malignant transformation of bone lesions, although rare, poses a major diagnostic and clinical challenge. Common benign lesions (e.g., osteochondroma, enchondroma, fibrous dysplasia, giant cell tumor), non-tumorous conditions (...

(This article belongs to the Special Issue Advances in the Diagnosis and Management of Bone Diseases in 2025)
  • Article
  • Open Access
6 Citations
3,533 Views
7 Pages

Subsequent Malignant Neoplasm of Bone in Children and Adolescent—Possibility of Multimodal Treatment

  • Anna Raciborska,
  • Katarzyna Bilska,
  • Tomasz Koziński and
  • Carlos Rodriguez-Galindo

11 February 2022

Background: In recent years, modifications of treatment protocols introduced in pediatric oncology have resulted in a significant improvement in treatment outcomes. Unfortunately, the probability of subsequent malignant neoplasm (SMN) in this group o...

(This article belongs to the Section Bone and Soft Tissue Oncology)
  • Article
  • Open Access
7 Citations
3,147 Views
14 Pages

Somatic Disease in Survivors of Childhood Malignant Bone Tumors in the Nordic Countries

  • Camilla Pedersen,
  • Catherine Rechnitzer,
  • Elisabeth Anne Wreford Andersen,
  • Line Kenborg and ,
  • Filippa Nyboe Norsker,
  • Andrea Bautz,
  • Thomas Baad-Hansen,
  • Laufey Tryggvadottir,
  • Laura-Maria Madanat-Harjuoja and
  • on behalf of the ALiCCS Study Group
  • + 9 authors+ 4 authors

7 September 2021

Survivors of malignant bone tumors in childhood are at risk of long-term adverse health effects. We comprehensively reviewed cases of somatic diseases that required a hospital contact in survivors of osteosarcoma and Ewing sarcoma. In a population-ba...

(This article belongs to the Special Issue Pediatric Cancers)
  • Article
  • Open Access
7 Citations
3,838 Views
9 Pages

Impaired Alignment of Bone Matrix Microstructure Associated with Disorganized Osteoblast Arrangement in Malignant Melanoma Metastasis

  • Aira Matsugaki,
  • Yumi Kimura,
  • Ryota Watanabe,
  • Fumihito Nakamura and ,
  • Ryo Takehana and
  • Takayoshi Nakano
  • + 1 author+ 0 author

20 January 2021

Malignant melanoma favors spreading to bone, resulting in a weakened bone with a high fracture risk. Here, we revealed the disorganized alignment of apatite crystals in the bone matrix associated with the homing of cancer cells by developing an artif...

(This article belongs to the Section Molecular Medicine)
  • Article
  • Open Access
1 Citations
3,321 Views
16 Pages

Malignant Giant Cell Tumor of Bone: A Study of Clinical, Pathological, and Prognostic Profile from One Single Center

  • Jingtian Shi,
  • Xin Sun,
  • Jichuan Wang,
  • Haijie Liang and ,
  • Xingyu Liu,
  • Yi Yang,
  • Xiaodong Tang and
  • Wei Guo
  • + 3 authors+ 0 author

Malignant giant cell tumor of bone (GCTB) is a rare malignant bone tumor. This analysis was conducted on patients with malignant GCTB at our center. The clinical, demographic, and prognostic characteristics were evaluated and compared. During 1 Janua...

(This article belongs to the Section Cellular and Molecular Bioengineering)
  • Article
  • Open Access
43 Citations
4,173 Views
22 Pages

An Intelligent Auxiliary Framework for Bone Malignant Tumor Lesion Segmentation in Medical Image Analysis

  • Xiangbing Zhan,
  • Jun Liu,
  • Huiyun Long,
  • Jun Zhu and ,
  • Haoyu Tang,
  • Fangfang Gou and
  • Jia Wu
  • + 2 authors+ 0 author

Bone malignant tumors are metastatic and aggressive, with poor treatment outcomes and prognosis. Rapid and accurate diagnosis is crucial for limb salvage and increasing the survival rate. There is a lack of research on deep learning to segment bone m...

(This article belongs to the Special Issue Advances in Machine Learning for Computer-Aided Diagnosis in Biomedical Imaging)
  • Article
  • Open Access
17 Citations
4,143 Views
12 Pages

Late Local Recurrence of Bone Giant Cell Tumors Associated with an Increased Risk for Malignant Transformation

  • Shinji Tsukamoto,
  • Alberto Righi,
  • Andreas F. Mavrogenis,
  • Manabu Akahane and ,
  • Kanya Honoki,
  • Yasuhito Tanaka,
  • Davide Maria Donati and
  • Costantino Errani
  • + 3 authors+ 0 author

20 July 2021

In giant cell tumor of bone (GCTB), an intermediate malignant bone tumor, approximately 4% of all cases undergo malignant transformation. Accordingly, we analyzed risk factors for malignant transformation of GCTB treated without radiotherapy. We retr...

(This article belongs to the Special Issue Research Advances in Giant Cell Tumor of Bone)
  • Systematic Review
  • Open Access
5 Citations
3,182 Views
12 Pages

Effect of Adjuvant Chemotherapy on Localized Malignant Giant Cell Tumor of Bone: A Systematic Review

  • Rokuro Morii,
  • Shinji Tsukamoto,
  • Alberto Righi,
  • Kanya Honoki and ,
  • Yuu Tanaka,
  • Akira Kido,
  • Hiromasa Fujii,
  • Andreas F. Mavrogenis,
  • Yasuhito Tanaka and
  • Costantino Errani
  • + 5 authors+ 0 author

28 October 2021

A malignant giant cell tumor of the bone (GCTB) is a rare primary malignant tumor classified as primary or secondary. Wide resection of the primary tumor is recommended for localized malignant GCTB, but the effect of adjuvant chemotherapy is unclear....

(This article belongs to the Special Issue Research Advances in Giant Cell Tumor of Bone)
  • Article
  • Open Access
3 Citations
2,017 Views
10 Pages

Background: Due to the scarcity of cases, adjustments for confounding factors in analyses of the effects of postoperative infections on limb function after surgery for malignant bone and soft tissue tumors were insufficient in previous studies. One s...

(This article belongs to the Section Bone and Soft Tissue Oncology)
  • Review
  • Open Access
37 Citations
8,413 Views
27 Pages

The Bone Marrow Microenvironment in B-Cell Development and Malignancy

  • Anastasia M. Hughes,
  • Vincent Kuek,
  • Rishi S. Kotecha and
  • Laurence C. Cheung

22 April 2022

B lymphopoiesis is characterized by progressive loss of multipotent potential in hematopoietic stem cells, followed by commitment to differentiate into B cells, which mediate the humoral response of the adaptive immune system. This process is tightly...

(This article belongs to the Special Issue The Role of Immune Cells in the Tumor Microenvironment)
  • Article
  • Open Access
2 Citations
2,229 Views
9 Pages

The Association between Race/Ethnicity and Cancer Stage at Diagnosis of Bone Malignancies: A Retrospective Cohort Study

  • Ayman Oweisi,
  • Moawiah S. Mustafa,
  • Luai S. Mustafa,
  • Alyssa N. Eily and ,
  • Pura Rodriguez de la Vega,
  • Grettel Castro and
  • Noël C. Barengo
  • + 2 authors+ 0 author

Introduction and objective: Limited data exists analyzing disparities in diagnosis regarding primary bone neoplasms (PBN). The objective of our study was to determine if there is an association between race/ethnicity and advanced stage of diagnosis o...

  • Article
  • Open Access
795 Views
13 Pages

From Survival to Living: A Comprehensive Analysis of Fibula Graft Complications, Functional Outcomes, and Quality of Life Following Reconstruction for Malignant Bone Tumors

  • Beatrice Jung,
  • Isabel Sperrhake,
  • Saskia Sachsenmaier,
  • Tilmann Busse and ,
  • Eren Demir,
  • Maria Christina Stefanescu,
  • Constantin Doetsch,
  • Sophie Zorn and
  • Frank Traub
  • + 4 authors+ 0 author

10 May 2026

Background: Although survival rates for patients with malignant bone tumors have improved significantly, complications following tumor resection and limb-sparing reconstruction remain a major clinical challenge, particularly in young individuals. Int...

  • Article
  • Open Access
11 Citations
3,105 Views
11 Pages

The Bateman-Type Soft Tissue Reconstruction around Proximal or Total Humeral Megaprostheses in Patients with Primary Malignant Bone Tumors—Functional Outcome and Endoprosthetic Complications

  • Helmut Ahrens,
  • Christoph Theil,
  • Georg Gosheger,
  • Robert Rödl and ,
  • Niklas Deventer,
  • Carolin Rickert,
  • Thomas Ackmann,
  • Jan Schwarze,
  • Sebastian Klingebiel and
  • Kristian Nikolaus Schneider
  • + 5 authors+ 0 author

5 August 2021

We aimed to evaluate the functional outcome and endoprosthetic complications following the Bateman-type soft tissue reconstruction around proximal or total humeral replacements in patients undergoing resection of a primary malignant bone tumor. Betwe...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Review
  • Open Access
18 Citations
6,937 Views
13 Pages

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application

  • Sonali Nayak,
  • Ashorne Mahenthiran,
  • Yongyong Yang,
  • Mark McClendon and ,
  • Barbara Mania-Farnell,
  • Charles David James,
  • John A. Kessler,
  • Tadanori Tomita,
  • Shi-Yuan Cheng and
  • Guifa Xi
  • + 6 authors+ 1 author

24 February 2020

Malignant gliomas are heterogeneous neoplasms. Glioma stem-like cells (GSCs) are undifferentiated and self-renewing cells that develop and maintain these tumors. These cells are the main population that resist current therapies. Genomic and epigenomi...

(This article belongs to the Special Issue Pediatric Brain Tumor)
  • Article
  • Open Access
1 Citations
1,344 Views
15 Pages

Utility of Same-Modality, Cross-Domain Transfer Learning for Malignant Bone Tumor Detection on Radiographs: A Multi-Faceted Performance Comparison with a Scratch-Trained Model

  • Joe Hasei,
  • Ryuichi Nakahara,
  • Yujiro Otsuka,
  • Koichi Takeuchi and ,
  • Yusuke Nakamura,
  • Kunihiro Ikuta,
  • Shuhei Osaki,
  • Hironari Tamiya,
  • Shinji Miwa and
  • Toshifumi Ozaki
  • + 12 authors+ 7 authors

27 September 2025

Background/Objectives: Developing high-performance artificial intelligence (AI) models for rare diseases like malignant bone tumors is limited by scarce annotated data. This study evaluates same-modality cross-domain transfer learning by comparing an...

(This article belongs to the Special Issue Novel Approaches to Machine Learning and Artificial Intelligence in Cancer Research and Care (2nd Edition))
  • Article
  • Open Access
1 Citations
585 Views
18 Pages

8 July 2026

Background: The survival benefit of primary tumor resection (PTR) in patients with synchronous metastatic primary malignant bone neoplasms (PMBNs) remains controversial. We aimed to evaluate the association between PTR and survival outcomes using a l...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Article
  • Open Access

Association of the Lymphocyte/Monocyte Ratio and C-Reactive Protein with Bone Lesion Characteristics: An Exploratory Study

  • Eyup Senocak,
  • Adem Keskin,
  • Fatih Emre Topsakal,
  • Muhammet Celik and ,
  • Ibrahim Dag,
  • Roein Arjmandi Akram and
  • Islam Gozun
  • + 2 authors+ 0 author

16 November 2026

Background/Objectives: This study aimed to investigate the associations of the lymphocyte/monocyte ratio (LMR) and C-reactive protein (CRP) with bone lesions and to assess their relationships with lesion characteristics and histopathological subgroup...

(This article belongs to the Section Clinical Laboratory Medicine)
  • Article
  • Open Access
6 Citations
4,771 Views
13 Pages

Recipient ADAMTS13 Single-Nucleotide Polymorphism Predicts Relapse after Unrelated Bone Marrow Transplantation for Hematologic Malignancy

  • Haruka Nomoto,
  • Akiyoshi Takami,
  • J. Luis Espinoza,
  • Makoto Onizuka and ,
  • Koichi Kashiwase,
  • Yasuo Morishima,
  • Takahiro Fukuda,
  • Yoshihisa Kodera,
  • Noriko Doki and
  • Eriko Morishita
  • + 8 authors+ 3 authors

Relapse remains a major obstacle to the survival of patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation. A disintegrin-like and metalloprotease with a thrombospondin type 1 motif (ADMATS13), which cleaves v...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
1 Citations
2,267 Views
13 Pages

What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity

  • Maya Niethard,
  • Carolin Knebel,
  • Andreas Leithner,
  • Per-Ulf Tunn and ,
  • Janosch Schoon,
  • Peter Reichardt,
  • Athanasios Pogkas,
  • Joanna Szkandera,
  • Daniel Pink and
  • Dimosthenis Andreou
  • + 5 authors+ 0 author

24 April 2024

Primary leiomyosarcoma of bone (LMSoB) is extremely rare, comprising only <0.7% of primary malignant bone tumors, and is therefore considered an ultra-rare tumor entity. There is currently no consensus as to whether therapeutic strategies should b...

(This article belongs to the Section Cancer Pathophysiology)
  • Review
  • Open Access
9 Citations
2,871 Views
19 Pages

4 August 2025

Despite significant advancements in understanding the pathogenesis and treatment of hematological malignancies, including leukemia and multiple myeloma, the majority of patients continue to experience poor long-term outcomes. This is partly due to th...

(This article belongs to the Section Tumor Microenvironment)
  • Review
  • Open Access
26 Citations
19,568 Views
21 Pages

Current Concepts in the Treatment of Giant Cell Tumor of Bone: An Update

  • Shinji Tsukamoto,
  • Andreas F. Mavrogenis,
  • Tomoya Masunaga,
  • Kanya Honoki and ,
  • Hiromasa Fujii,
  • Akira Kido,
  • Yasuhito Tanaka and
  • Costantino Errani
  • + 3 authors+ 0 author

8 April 2024

Curettage is recommended for the treatment of Campanacci stages 1–2 giant cell tumor of bone (GCTB) in the extremities, pelvis, sacrum, and spine, without preoperative denosumab treatment. In the distal femur, bone chips and plate fixation are...

(This article belongs to the Section Bone and Soft Tissue Oncology)
  • Article
  • Open Access
10 Citations
3,017 Views
12 Pages

The Hypercoagulable Profile of Patients with Bone Tumors: A Pilot Observational Study Using Rotational Thromboelastometry

  • Andreas G. Tsantes,
  • Ilectra Loukopoulou,
  • Dimitrios V. Papadopoulos,
  • Ioannis G. Trikoupis and ,
  • Anastasios G. Roustemis,
  • Stavros Goumenos,
  • Rozeta Sokou,
  • Konstantina A. Tsante,
  • Anastasios G. Kriebardis and
  • Argirios E. Tsantes
  • + 10 authors+ 5 authors

15 August 2022

Introduction: A detailed evaluation of the malignancy-associated coagulopathy (MAC) in surgical patients with bone tumors may allow for more effective thromboprophylactic measures. The purpose of this study was to assess the perioperative hemostatic...

  • Article
  • Open Access
7 Citations
4,474 Views
13 Pages

Secondary Malignancy in Giant Cell Tumor: A Single-Center Study

  • Min Wook Joo,
  • Yong-Suk Lee,
  • Hong Sik Park,
  • Yang-Guk Chung and
  • Chiyoung Yoon

2 June 2022

Giant cell tumor of bone (GCTB) undergoes a sarcomatous transformation. Secondary malignancy in giant cell tumor (MGCT) is associated with radiotherapy and has a dismal prognosis. We reviewed medical records to investigate the clinicopathological cha...

  • Review
  • Open Access
38 Citations
18,431 Views
35 Pages

Multimodal Imaging of Osteosarcoma: From First Diagnosis to Radiomics

  • Maurizio Cè,
  • Michaela Cellina,
  • Thirapapha Ueanukul,
  • Gianpaolo Carrafiello and ,
  • Rawee Manatrakul,
  • Phatthawit Tangkittithaworn,
  • Suphaneewan Jaovisidha,
  • Praman Fuangfa and
  • Donald Resnick
  • + 4 authors+ 0 author

10 February 2025

Osteosarcoma is a primary malignant bone tumor characterized by the production of an osteoid matrix. Although histology remains the definitive diagnostic standard, imaging plays a crucial role in diagnosis, therapeutic planning, and follow-up. Conven...

(This article belongs to the Special Issue Advances in Oncological Imaging)
  • Review
  • Open Access
14 Citations
4,092 Views
18 Pages

Systematic Review of Tumor Segmentation Strategies for Bone Metastases

  • Iromi R. Paranavithana,
  • David Stirling,
  • Montserrat Ros and
  • Matthew Field

14 March 2023

Purpose: To investigate the segmentation approaches for bone metastases in differentiating benign from malignant bone lesions and characterizing malignant bone lesions. Method: The literature search was conducted in Scopus, PubMed, IEEE and MedLine,...

(This article belongs to the Section Systematic Review or Meta-Analysis in Cancer Research)
  • Article
  • Open Access
13 Citations
4,987 Views
9 Pages

Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB)

  • Melanie Barz,
  • Kaywan Aftahy,
  • Insa Janssen,
  • Yu-Mi Ryang and ,
  • Georg Prokop,
  • Stephanie E. Combs,
  • Philipp J. Jost,
  • Bernhard Meyer and
  • Jens Gempt
  • + 4 authors+ 0 author

2 October 2021

Manifestation of malignant lymphoma in the spine is rare; there have only been a few cases reported in the literature. Due to its rarity, there is no gold standard for the management of patients suffering from spinal lymphoma manifestations. Methods:...

  • Review
  • Open Access
144 Views
19 Pages

Background: The presence of cancer cells in the bone marrow can cause blood cell abnormalities; when bone marrow metastasis is suspected, aspiration is performed to test for hematological disorders. However, the usefulness of combining cell surface m...

(This article belongs to the Special Issue Advancements in Blood Sample Analysis: Innovative Technologies for Hematology)
  • Interesting Images
  • Open Access
2,729 Views
7 Pages

Problematic Imaging Diagnostics of Musculoskeletal Gossypiboma with Chronic Expanding Hematoma Mimicking Malignant Lesion

  • Tomas Kucera,
  • Libor Prokes,
  • Jiri Soukup,
  • Jindra Brtkova and ,
  • Ondrej Valtr and
  • Pavel Sponer
  • + 1 author+ 0 author

Both musculoskeletal gossypibomas and chronic expanding hematomas have been rarely reported; the reports that do exist are usually case reports. Our objective is to demonstrate problematic imaging diagnostics of an unusual presentation mimicking a ma...

(This article belongs to the Special Issue Imaging of Musculoskeletal Diseases: New Advances and Future Trends)
  • Review
  • Open Access
20 Citations
6,027 Views
15 Pages

Vertebral Primary Bone Lesions: Review of Management Options

  • Anjalika Chalamgari,
  • Daisy Valle,
  • Xuban Palau Villarreal,
  • Marco Foreman and ,
  • Annika Liu,
  • Aashay Patel,
  • Akanksha Dave and
  • Brandon Lucke-Wold
  • + 3 authors+ 0 author

4 March 2023

The assessment and treatment of vertebral primary bone lesions continue to pose a unique yet significant challenge. Indeed, there exists little in the literature in the way of compiling and overviewing the various types of vertebral lesions, which ca...

  • Article
  • Open Access
7 Citations
3,704 Views
24 Pages

The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment

  • Karnoon Shamsoon,
  • Daichi Hiraki,
  • Koki Yoshida,
  • Kiyofumi Takabatake and ,
  • Hiroaki Takebe,
  • Kenji Yokozeki,
  • Naohiro Horie,
  • Naomasa Fujita,
  • Nisrina Ekayani Nasrun and
  • Tsuyoshi Shimo
  • + 10 authors+ 5 authors

A crucial regulator in melanoma progression and treatment resistance is tumor microenvironments, and Hedgehog (Hh) signals activated in a tumor bone microenvironment are a potential new therapeutic target. The mechanism of bone destruction by melanom...

(This article belongs to the Special Issue Hedgehog Signaling 3.0)
  • Review
  • Open Access
69 Citations
15,808 Views
17 Pages

Current Concepts in the Treatment of Giant Cell Tumors of Bone

  • Shinji Tsukamoto,
  • Andreas F. Mavrogenis,
  • Akira Kido and
  • Costantino Errani

21 July 2021

The 2020 World Health Organization classification defined giant cell tumors of bone (GCTBs) as intermediate malignant tumors. Since the mutated H3F3A was found to be a specific marker for GCTB, it has become very useful in diagnosing GCTB. Curettage...

(This article belongs to the Special Issue Research Advances in Giant Cell Tumor of Bone)
  • Case Report
  • Open Access
2 Citations
4,328 Views
11 Pages

Giant Sternal Chondrosarcoma in a 50-Year-Old Patient

  • Cezar Pavelescu,
  • Alexandru Bebliuc,
  • Rareș Asmarandei,
  • Maria Sabina Safta and ,
  • Ondin Zaharia,
  • Victor Sebastian Costache,
  • Adrian Molnar,
  • Daniela Gheorghiță,
  • Cristian Voica and
  • Horațiu Moldovan
  • + 5 authors+ 0 author

14 January 2022

Chondrosarcomas represent approximately 20% of primary malignant bone cancers, being known as the most frequent neoplasia of the anterior thoracic wall. In our case, we present a case of a primary sternal chondrosarcoma in a 50-year-old female patien...

  • Review
  • Open Access
41 Citations
8,072 Views
23 Pages

Extracellular Vesicles in Hematological Malignancies: From Biology to Therapy

  • Antonella Caivano,
  • Francesco La Rocca,
  • Ilaria Laurenzana,
  • Stefania Trino and ,
  • Luciana De Luca,
  • Daniela Lamorte,
  • Luigi Del Vecchio and
  • Pellegrino Musto
  • + 3 authors+ 0 author

Extracellular vesicles (EVs) are a heterogeneous group of particles, between 15 nanometers and 10 microns in diameter, released by almost all cell types in physiological and pathological conditions, including tumors. EVs have recently emerged as part...

(This article belongs to the Special Issue Extracellular Vesicles for Therapeutic Applications: What’s the Story?)
  • Article
  • Open Access
10 Citations
4,079 Views
18 Pages

Effects of Soy–Whey Protein Nutritional Supplementation on Hematopoiesis and Immune Reconstitution in an Allogeneic Transplanted Mice

  • Xiaoliang Wu,
  • Qinghua Hou,
  • Zhenyu Zhao,
  • Jing Wang and ,
  • Yanzhi Guo,
  • Lingang Lu and
  • Juan Han
  • + 2 authors+ 0 author

22 July 2022

Profound malnutrition and immunodeficiency are serious negative effects of radiotherapy and bone marrow transplantation for hematologic malignancy patients. This study aimed to evaluate the effects of nutritional supplementation with a soy–whey...

(This article belongs to the Section Proteins and Amino Acids)
  • Case Report
  • Open Access
8 Citations
3,208 Views
5 Pages

Langerhans cell histiocytosis (LCH) is a rare neoplastic disorder characterized by the clonal proliferation of CD1a +/CD 207 + dendritic cells, whose features are similar to those of epidermal Langerhans cells. LCH is more common in children than in...

(This article belongs to the Section Medical Imaging and Theranostics)
  • Review
  • Open Access
31 Citations
8,545 Views
27 Pages

Past, Present, and a Glance into the Future of Multiple Myeloma Treatment

  • Weam Othman Elbezanti,
  • Kishore B. Challagundla,
  • Subash C. Jonnalagadda,
  • Tulin Budak-Alpdogan and
  • Manoj K. Pandey

Multiple myeloma (MM) is a challenging hematological cancer which typically grows in bone marrow. MM accounts for 10% of hematological malignancies and 1.8% of cancers. The recent treatment strategies have significantly improved progression-free surv...

(This article belongs to the Special Issue Drug Candidates for the Treatment of Multiple Myeloma)
  • Review
  • Open Access
1 Citations
2,154 Views
36 Pages

Telomere Length Abnormality: Investigating Approaches and Correlations with Cancer, Bone Marrow Failure and Hematological Malignancies

  • Corrado Tarella,
  • Dario Ferrero,
  • Maria Beatriz Herrera Sanchez,
  • Alessia Rita Canestrale and ,
  • Sharad Kholia,
  • Lorenzo Silengo,
  • Enrico Derenzini and
  • Irene Ricca
  • + 3 authors+ 0 author

Proper telomere maintenance is crucial for ensuring healthy cellular function. Telomeres have a tendency to reduce in length with cellular aging. Moreover several factors may promote telomere attrition. Other conditions, primarily due to genetic and...

(This article belongs to the Special Issue The Role of Telomere and Telomerase in Human Disease—2nd Edition)
  • Review
  • Open Access
54 Citations
13,700 Views
22 Pages

Bone marrow adipocytes (BMA) exert pleiotropic roles beyond mere lipid storage and filling of bone marrow (BM) empty spaces, and we are only now beginning to understand their regulatory traits and versatility. BMA arise from the differentiation of BM...

(This article belongs to the Section Hematology)
  • Interesting Images
  • Open Access
974 Views
11 Pages

Hematological Malignancy in a Hypophysectomised Acromegalic Patient Under 4-Year Therapy with Somatostatin Analogues: From a Rib Lump Underlying Bone Plasmatocytoma Features to Multiple Myeloma

  • Mihaela Stanciu,
  • Alina Cătană,
  • Ruxandra Paula Ristea,
  • Denisa Tanasescu and ,
  • Mara Carsote,
  • Florina Ligia Popa and
  • Ioana-Codruța Lebădă
  • + 2 authors+ 0 author

17 October 2025

Acromegaly is associated with a higher risk of certain malignancies, but not hematological neoplasia, although multiple myeloma (MM) was found in very limited cases. We aim to present such a case, adding a particular presentation with co-occurrence o...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
7 Citations
5,161 Views
12 Pages

Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma

  • Haruya Okamoto,
  • Nobuhiko Uoshima,
  • Ayako Muramatsu,
  • Reiko Isa and ,
  • Takahiro Fujino,
  • Yayoi Matsumura-Kimoto,
  • Taku Tsukamoto,
  • Shinsuke Mizutani,
  • Yuji Shimura and
  • Kyoto Clinical Hematology Study Group Investigators
  • + 9 authors+ 4 authors

20 September 2021

Bone marrow (BM) involvement is associated with prognosis in diffuse large B-cell lymphoma (DLBCL), the most prevalent disease subtype of malignant lymphoma. We conducted this multi-institutional retrospective study to investigate the functional asso...

(This article belongs to the Topic Cancer Biology and Therapy)
  • Article
  • Open Access
2 Citations
2,972 Views
16 Pages

Outlining the Clinical Profile of TCIRG1 14 Variants including 5 Novels with Overview of ARO Phenotype and Ethnic Impact in 20 Egyptian Families

  • Ghada Y. El-Kamah,
  • Mennat I. Mehrez,
  • Mohamed B. Taher,
  • Hala T. El-Bassyouni and ,
  • Khaled R. Gaber and
  • Khalda S. Amr
  • + 1 author+ 0 author

12 April 2023

TCIRG1 gene mutations underlie osteopetrosis, a rare genetic disorder impacting osteoclast function with consequent brittle bones prone to fracture, in spite of being characterized by increased bone density. The disorder is known to exhibit marked ge...

(This article belongs to the Special Issue Feature Papers in Human Genomics and Genetic Diseases)
  • Review
  • Open Access
41 Citations
7,542 Views
14 Pages

Rare Primary Malignant Bone Sarcomas

  • Emanuela Palmerini,
  • Alberto Righi and
  • Eric L. Staals

23 October 2020

Rare primary malignant bone sarcomas (RPMBS), other than osteosarcoma, chondrosarcoma, chordoma, and Ewing sarcoma, account for about 5–10% of primary bone tumors and represent a major diagnostic challenge. These tumors include spindle cell and...

(This article belongs to the Special Issue New Therapeutic Advances in Rare Tumors)
  • Review
  • Open Access
13 Citations
14,022 Views
16 Pages

Malignant Bone and Soft Tissue Lesions of the Foot

  • Andrea Angelini,
  • Carlo Biz,
  • Mariachiara Cerchiaro,
  • Valentina Longhi and
  • Pietro Ruggieri

21 April 2023

Malignant tumors of the foot are rare pathologies that can involve the skin, soft tissue, or bone. Due to their rarity, they are often misdiagnosed, resulting in inadequate excision and poor outcomes. A correct approach with a careful examination and...

(This article belongs to the Special Issue Updates in the Orthopedic Management of Foot Disorders)
  • Review
  • Open Access
11 Citations
3,838 Views
15 Pages

MicroRNAs as Prognostic Biomarkers and Therapeutic Targets in Chondrosarcoma

  • Palina Skipar,
  • Mritunjoy Dey,
  • Jakub Piątkowski,
  • Dorota Sulejczak and ,
  • Piotr Rutkowski and
  • Anna M. Czarnecka
  • + 1 author+ 0 author

Chondrosarcoma, the second most common primary malignant bone tumor, originates from cartilaginous tissue and accounts for almost 20% of all primary bone tumors. The management of chondrosarcoma remains challenging due to its diverse clinical course...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
1 Citations
1,081 Views
31 Pages

Comparative Molecular Insights and Computational Modeling of Multiple Myeloma and Osteosarcoma

  • Alina Ioana Ghiță,
  • Vadim V. Silberschmidt and
  • Mariana Ioniță

Multiple myeloma (MM) and osteosarcoma (OS) are two biologically distinct osseous malignancies with similar molecular networks that present translational challenges for their computational modeling. This comparative research analyzes MM and OS biolog...

(This article belongs to the Section Molecular Oncology)

of 35